Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Advances in Clinical RadiologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Fifth edition. Stevens & Lowe’s human histology. viii. Elsevier, Philadelphia2020: 426
- Carotid body chemoreceptors: physiology, pathology, and implications for health and disease.Physiol Rev. 2021; 101: 1177-1235
- From the archives of the AFIP. Paragangliomas of the head and neck: radiologic-pathologic correlation. Armed Forces Institute of Pathology.Radiographics. 1999; 19: 1605-1632
- Tumors of the extra-adrenal paraganglion system (including chemoreceptors). Atlas of tumor pathology.Armed Forces Institute of Pathology, 1974: 90 (for sale by the American Registry of Pathology, Armed Forces Institute of Pathology)
- Intravagal paragangliomas: report of four cases.Neurosurgery. 1996; 38 ([discussion: 575]): 569-575
- Head and neck paragangliomas: a two-decade institutional experience and algorithm for management.Laryngoscope Investig Otolaryngol. 2017; 2: 380-389
- Head-and-neck paragangliomas: an overview of 54 cases operated at a tertiary care center.South Asian J Cancer. 2019; 8: 237-240
- High altitude hypoxia and chemodectomas.Hum Pathol. 1973; 4: 251-263
- Positive impact of genetic test on the management and outcome of patients with paraganglioma and/or pheochromocytoma.J Clin Endocrinol Metab. 2019; 104: 1109-1118
- Subject based registration for individualized analysis of diffusion tensor MRI.PLoS One. 2015; 10: e0142288
- Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours.Endocr Pathol. 2017; 28: 213-227
- National Cancer Data Base report on malignant paragangliomas of the head and neck.Cancer. 2002; 94: 730-737
- Pheochromocytomas and paragangliomas: new developments with regard to classification, genetics, and cell of origin.Cancers (Basel). 2019; 11: 1070
- Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma.Endocr Relat Cancer. 2014; 21: 405-414
- Malignant head and neck paragangliomas: is there an optimal treatment strategy?.Head Neck Oncol. 2010; 2: 23
- Current trends in the detection and management of carotid body tumors.J Vasc Surg. 1998; 28 ([discussion: 92-3]): 84-92
- Head and neck paragangliomas: an update on evaluation and management.Otolaryngol Head Neck Surg. 2016; 154: 597-605
- Comprehensive molecular characterization of pheochromocytoma and paraganglioma.Cancer Cell. 2017; 31: 181-193
- Current management of pheochromocytoma/paraganglioma: a guide for the practicing clinician in the Era of precision medicine.Cancers (Basel). 2019; 11: 1505
- Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.Clin Transl Oncol. 2021; 23: 1995-2019
- Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.J Clin Endocrinol Metab. 2014; 99: 1915-1942
- New perspectives on pheochromocytoma and paraganglioma: toward a molecular classification.Endocr Rev. 2017; 38: 489-515
- Head and neck paragangliomas-A genetic overview.Int J Mol Sci. 2020; 21: 7669
- Personalized management of pheochromocytoma and paraganglioma.Endocr Rev. 2021; https://doi.org/10.1210/endrev/bnab019
- Prognosis of malignant pheochromocytoma and paraganglioma (MAPP-Prono Study): a european network for the study of adrenal tumors retrospective study.J Clin Endocrinol Metab. 2019; 104: 2367-2374
- SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes.J Intern Med. 2009; 266: 19-42
- MR imaging of paragangliomas.AJR Am J Roentgenol. 1987; 148: 201-204
- MR diagnosis of paraganglioma of the head and neck: value of contrast enhancement.AJR Am J Roentgenol. 1994; 162: 147-153
- Glomus tumors of the skull base: combined use of MR angiography and spin-echo imaging.Radiology. 1994; 192: 103-110
- Tumors of the parapharyngeal space and upper neck: MR imaging characteristics.Radiology. 1987; 164: 823-829
- Angiography. Radiology of the skull and brain, v 2.Mosby, St. Louis1974
- Cranial nerve schwannomas: diagnostic imaging approach.Radiographics. 2016; 36: 1463-1477
- Dynamic contrast-enhanced MR perfusion imaging of head and neck tumors at 3 Tesla.Head Neck. 2013; 35: 923-929
- Guidelines for the use and interpretation of assays for monitoring autophagy.Autophagy. 2012; 8: 445-544
- Head and neck paragangliomas: diffusion weighted and dynamic contrast enhanced magnetic resonance imaging characteristics.BMC Med Imaging. 2016; 16: 12
- Dynamic contrast-enhanced MRI in the evaluation of carotid space paraganglioma versus schwannoma.J Neuroimaging. 2016; 26: 618-625
- Dynamic contrast-enhanced magnetic resonance imaging for differentiating head and neck paraganglioma and schwannoma.Head Neck. 2021; 43: 2611-2622
- Diagnostic role of diffusion-weighted and dynamic contrast-enhanced perfusion MR imaging in paragangliomas and schwannomas in the head and neck.AJNR Am J Neuroradiol. 2021; 42: 1839-1846
- Dynamic contrast enhancement of paragangliomas of the head and neck: evaluation with time-resolved 2D MR projection angiography.Eur Radiol. 2003; 13: 1608-1611
- Optimized time-resolved 3D contrast-enhanced MRA at 3T: appreciating the feasibility of assessing cervical paragangliomas.J Neuroradiol. 2010; 37: 104-108
- Feasibility of non-contrast-enhanced four dimensional (4D) MRA in head and neck tumors, comparison with contrast-enhanced 4D MRA.Springerplus. 2016; 5: 1282
- Quantitative biomarkers allow the diagnosis of head and neck paraganglioma on multiparametric MRI.Eur J Radiol. 2021; 143: 109911
- Diffusion-weighted imaging and ADC mapping of head-and-neck paragangliomas: initial experience.Klin Neuroradiol. 2009; 19: 215-219
- Assessment of MR imaging and CT in differentiating hereditary and nonhereditary paragangliomas.AJNR Am J Neuroradiol. 2021; 42: 1320-1326
- Quantitative comparison of algorithms for inter-subject registration of 3D volumetric brain MRI scans. Comparative Study.J Neurosci Methods. 2005; 142: 67-76
- Head and neck paragangliomas: value of contrast-enhanced 3D MR angiography.AJNR Am J Neuroradiol. 2008; 29: 883-889
- The value of a rapid contrast-enhanced angio-MRI protocol in the detection of head and neck paragangliomas in SDHx mutations carriers: a retrospective study on behalf of the PGL.EVA investigators.Eur Radiol. 2016; 26: 1696-1704
- Diffusion-weighted imaging (DWI) highlights SDHB-related tumours: a pilot study.Clin Endocrinol (Oxf). 2019; 91: 104-109
- Magnetic resonance spectroscopy of paragangliomas: new insights into in vivo metabolomics.Endocr Relat Cancer. 2015; 22: M1-M8
- Translating in vivo metabolomic analysis of succinate dehydrogenase deficient tumours into clinical utility.JCO Precis Oncol. 2018; 2: 1-12
- Succinate detection using in vivo (1)H-MR spectroscopy identifies germline and somatic SDHx mutations in paragangliomas.Eur J Nucl Med Mol Imaging. 2020; 47: 1510-1517
- European Association of Nuclear Medicine Practice Guideline/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma.Eur J Nucl Med Mol Imaging. 2019; 46: 2112-2137
- Precision medicine in phaeochromocytoma and paraganglioma.J Pers Med. 2021; 11https://doi.org/10.3390/jpm11111239
- 15 YEARS OF PARAGANGLIOMA: imaging and imaging-based treatment of pheochromocytoma and paraganglioma.Endocr Relat Cancer. 2015; 22: T135-T145
- Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.J Clin Endocrinol Metab. 2009; 94: 4757-4767
- False-negative (1)(2)(3)I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease.Endocr Relat Cancer. 2012; 19: 83-93
- European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma.Eur J Endocrinol. 2016; 174: G1-G10
- Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups.Endocr Relat Cancer. 2019; 26: R627-R652
- The Human SLC7A5 (LAT1): the Intriguing Histidine/Large Neutral Amino Acid Transporter and Its Relevance to Human Health.Front Chem. 2018; 6: 243
- Imaging of Pheochromocytoma and Paraganglioma.J Nucl Med. 2021; 62: 1033-1042
- Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma.Horm Metab Res. 2012; 44: 367-372
- 68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity.Cancer Imaging. 2016; 16: 22
- 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature?.J Nucl Med. 2009; 50: 711-717
- Performance of (68)Ga-DOTA-conjugated somatostatin receptor-targeting peptide pet in detection of pheochromocytoma and paraganglioma: a systematic review and metaanalysis.J Nucl Med. 2019; 60: 369-376
- Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas.Hum Pathol. 2015; 46: 390-396
- 68)Ga-somatostatin receptor analogs and (18)F-FDG PET/CT in the localization of metastatic pheochromocytomas and paragangliomas with germline mutations: a meta-analysis.Acta Radiol. 2018; 59: 1466-1474
- 68Ga-DOTATATE PET/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT/MRI.J Nucl Med. 2016; 57: 186-191
- Imaging features of succinate dehydrogenase-deficient pheochromocytoma-paraganglioma syndromes.Radiographics. 2019; 39: 1393-1410
- Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases.Am J Surg. 1971; 122: 732-739
- Surgical treatment of carotid body paragangliomas: outcomes and complications according to the shamblin classification.Clin Exp Otorhinolaryngol. 2010; 3: 91-95
- Carotid body tumors: objective criteria to predict the Shamblin group on MR imaging.AJNR Am J Neuroradiol. 2008; 29: 1349-1354
- Head and neck paragangliomas: report of 175 patients (1989-2010).Head Neck. 2012; 34: 632-637
- Vagal paraganglioma: a review of 46 patients treated during a 20-year period.Arch Otolaryngol Head Neck Surg. 1998; 124: 1133-1140
- A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors.J Neurosurg. 2011; 114: 1299-1305
- The role of wait-and-scan and the efficacy of radiotherapy in the treatment of temporal bone paragangliomas.Otol Neurotol. 2014; 35: 922-931
- Preoperative embolization of carotid body tumors: when is it appropriate?.Ann Vasc Surg. 1996; 10: 464-468
- Impact of preoperative embolization on outcomes of carotid body tumor resections.J Vasc Surg. 2012; 56: 979-989
- Incidence of cranial nerve palsy after preoperative embolization of glomus jugulare tumors using Onyx.J Neurosurg. 2014; 120: 377-381
- Excellent local control of paraganglioma in the head and neck with fractionated radiotherapy.Clin Oncol (R Coll Radiol. 2010; 22: 382-389
- Jugular and vagal paragangliomas: systematic study of management with surgery and radiotherapy.Head Neck. 2013; 35: 1195-1204
- Vagal paragangliomas.Otolaryngol Clin N Am. 2001; 34 (vi): 925-939
- Stereotactic radiosurgery in patients with glomus jugulare tumors.Neurosurg Focus. 2004; 17: E10
- Natural history of cervical paragangliomas: outcomes of observation of 43 patients.Arch Otolaryngol Head Neck Surg. 2012; 138: 341-345
- Natural history of glomus jugulare: a review of 16 tumors managed with primary observation.Otolaryngol Head Neck Surg. 2015; 152: 98-105
- Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal.Cancer. 2000; 88: 2811-2816
- Efficacy and safety of high-specific-activity (131)I-MIBG therapy in patients with advanced pheochromocytoma or paraganglioma.J Nucl Med. 2019; 60: 623-630
- A clinical efficacy of PRRT in Patients With advanced, nonresectable, paraganglioma-pheochromocytoma, related to SDHx gene mutation.J Clin Med. 2019; 8: 952
- Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: a systematic review and meta-analysis.Clin Endocrinol (Oxf). 2019; 91: 718-727
- Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials.ESMO Open. 2021; 6: 100171
- Peptide receptor radionuclide therapy in head and neck paragangliomas - Report of 14 cases.Rev Laryngol Otol Rhinol (Bord). 2015; 136: 155-158
- Peptide receptor radionuclide therapy with (90)Y/(177)Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours).Eur J Nucl Med Mol Imaging. 2015; 42: 1223-1230
- Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis.Clin Endocrinol (Oxf). 2014; 81: 642-651
- Successful second-line metronomic temozolomide in metastatic paraganglioma: case reports and review of the literature.Clin Med Insights Oncol. 2018; 12
- Clinical aspects of SDHA-related pheochromocytoma and paraganglioma: a nationwide study.J Clin Endocrinol Metab. 2018; 103: 438-445
- The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas.J Clin Endocrinol Metab. 2009; 94: 2817-2827
- An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma.Best Pract Res Clin Endocrinol Metab. 2020; 34: 101416
- SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma.Clin Cancer Res. 2011; 17: 247-254
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
